Cellular Proteases Involved in the Pathogenicity of Human Immunodeficiency and Influenza Viruses

  • Hiroshi Kido
  • Takae Towatari
  • Yasuharu Niwa
  • Yuushi Okumura
  • Yoshihito Beppu
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 389)

Abstract

Current understanding of the interactions between animal viruses and host cellular factors, such as virus receptors in the membrane and intracellular factors for viral replication, which determine the pathogenicity and infectious tropism of viruses, has considerably progressed. Current knowledge of membrane receptors for animal viruses are summarized in Table I. Viruses recognize and specifically bind to adhesion molecules in the membrane as receptors, many of which are members of the immunoglobulin (IgG) superfamily. These include the 70K IgG family of proteins for poliovirus, ICAM-1 for rhinovirus and CD4 for human immunodeficiency virus type-1 (HIV-1). Other virus receptors are receptors for hormones and proteins, such as the EGF receptor for vaccinia virus and ß-adrenergic receptor for reovirus, complement receptor for EB virus and sialic acid for influenza and Sendai viruses.

Keywords

Human Immunodeficiency Virus Type Influenza Virus Sialic Acid Pulmonary Surfactant Sendai Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Homma, M., and Ohuchi, M., 1973, Trypsin action on the growth of Sendai virus in tissue culture cell, J. Virol. 12: 1457–1465.PubMedGoogle Scholar
  2. 2.
    Klenk, H.-D., and Rott, R., 1988, The molecular biology of influenza virus pathogenicity, Adv. Virus Res. 34: 247–281.PubMedCrossRefGoogle Scholar
  3. 3.
    Rott, R., 1979, Molecular basis of infectivity and pathogenicity of myxoviruses, Arch. Virol. 59:285–298.PubMedCrossRefGoogle Scholar
  4. 4.
    Scheid, A., and Choppin, P.W., 1974, Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus, Virology 57: 475–490.PubMedCrossRefGoogle Scholar
  5. 5.
    Maddon, P.J., Dalgleish, A.G., and McDougal, J.S., 1986, The T4 gerne encodes the AIDS vius receptor and is expressed in the immune system and the brain, Cell 47: 333–348.PubMedCrossRefGoogle Scholar
  6. 6.
    Clapham, P.R., Blanc, D., and Weiss, R.A., 1991, Specific cell-surface requirements for infection of CD4-positive cells by human immunodeficiency virus type 1, type 2 and simian imunodeficiency virus, Virology 181: 703–715.PubMedCrossRefGoogle Scholar
  7. 7.
    Hattori, T., Koito, A., Takatsuki, K., Kido, H., and Katunuma, N., 1989, Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection, FEBS Lett. 248: 48–52.PubMedCrossRefGoogle Scholar
  8. 8.
    Kido, H., Fukutomi, A., and Katunuma, N., 1990, A novel membrane-bound serine esterae in human T4+ lymphocytes immunologically rective with antibody inhibiting syncytia induced by HIV-1. Purification and charcterization, J. Biol. Chem. 265: 21979–21985.PubMedGoogle Scholar
  9. 9.
    Kido, H., Fukutomi, A., and Katunuma, N., 1991, Tryptase TL2 in the membrane of human T4+ lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gpl20, FEBS Lett. 286: 233–236.PubMedCrossRefGoogle Scholar
  10. 10.
    Tashiro, M., and Homma, M., 1983, Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs, Infect. Immun. 39: 879–888.PubMedGoogle Scholar
  11. 11.
    Tashoro, M., Yamakawa, M., Tobita, K., Klenk, H.-D., Rott, R., and Seto, J.T., 1990, Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium, J. Virol. 64: 3627–3634.Google Scholar
  12. 12.
    Kido, H., Yokoigoshi, Y., Sakai, K., Tashiro, M., Kishino, Y., Fukutomi, A., and Katunuma, N., 1992, Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein, J. Biol. Chem. 267: 13573–13579.PubMedGoogle Scholar
  13. 13.
    Tashiro, M., Yokogoshi, Y., Tobita, K., Seto, J.T., Rott, R., and Kido, H., 1992, Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity, J. Virology 66: 7211–7216.PubMedGoogle Scholar
  14. 14.
    Kido, H., Sakai, K., Kishino, Y., and Tashiro, M., 1993, Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus, FEBS Lett., 322: 115–119.PubMedCrossRefGoogle Scholar
  15. 15.
    Hu, S.H., Kosowski, S.G., and Dalrymple, J.M., 1986, Expression of AIDS virus envelope gene in recombinant vaccinia viruses, Nature 320: 537–540.PubMedCrossRefGoogle Scholar
  16. 16.
    Travis, M.M., Dykers, T.T., Hu, S.-L., and Lewis, J.B., 1992, Functional role of the V3 hypervariable regions of HI V-1 gp 160 in the processing of gp 160 and in the formation of syncytia in CD4+ cells, Virology 186: 313–317.PubMedCrossRefGoogle Scholar
  17. 17.
    Kido, H., Kamoshita, K., Fukutomi, A., and Katunuma, N., 1993, Processing protease for gpl60 human immunodeficiency virus type 1 envelope glycoprotein precursor in human T4+ lymphocytes. Purification and characterization, J. Biol. Chem. 268: 13406–13413.PubMedGoogle Scholar
  18. 18.
    Ivanoff, L.A., Looney, D.J., McDanal, C., Morris, J.F., Wong-Stal, F., Langlois, A.J., Petteway, S.R., and Matthews, T.J., 1991, Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. AIDS Res. Hum. Retroviruses 1: 595–603.CrossRefGoogle Scholar
  19. 19.
    Javaherian, K., Langlois, A.J., McDanal, C., Ross, K.L., Eckler, L.L., Jellis, C.L., Profy, A.T., Rusche, J.R., Bolognesi, D.P., Putney, S.D., and Matthews, T.J., 1989, Principal neutralizing domain on the human immunodeficiency virus type 1 envelopoe protein, Proc. Natl. Acad. Sci. USA 86: 6768–6772.PubMedCrossRefGoogle Scholar
  20. 20.
    Putney, S., 1992, How antibodies block HIV infection: paths to an AIDS vaccine, TIBS 17: 191–196.PubMedGoogle Scholar
  21. 21.
    Kido, H., Yokogoshi, Y., and Katunuma, N., 1988, Kunitz type protease inhibitor found in rat mast cell: purification, properties and amino acid sequence, J. Biol. Chem. 263: 18104–18107.PubMedGoogle Scholar
  22. 22.
    Werner, A., and Levy, J.A., 1993, Human immunodeficiency virus type 1 envelope gpl20 is cleaved after incubation with recombinant soluble CD4, J. Virology 67: 2566–2574.PubMedGoogle Scholar
  23. 23.
    Clements, G.J., Price-Jones, M.J., Stephens, P.E., Sutton, C., Schulz, T.F., Clapham, PR., Mckeating, J.A., McClure, M.O., Thomson, S., Marsh, M., Kay, J., Weiss, R.A., and Moore, J.P., 1991, The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic clevage sites: a possible function in viral fusion, AIDS Research and Human Retroviruses 7:3–16.PubMedGoogle Scholar
  24. 24.
    Avril, L-E., Martino-Ferrer, M.D., Pignede, G., Seman, M., and Gauthier, F., 1994, Identification of the U-937 membrane-associated proteinase interacting with the V34 loop of HIV- gpl20 as cathepsin G, FEBS Lett. 345:81–86.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • Hiroshi Kido
    • 1
  • Takae Towatari
    • 1
  • Yasuharu Niwa
    • 1
  • Yuushi Okumura
    • 1
  • Yoshihito Beppu
    • 1
  1. 1.Division of Enzyme Chemistry, Institute for Enzyme ResearchThe University of TokushimaTokushimaJapan

Personalised recommendations